In a country where human blood is pooled through a national network but no equivalent exists for dogs, veterinary clinics in Japan are left to fend for themselves, sometimes with only a handful of donor animals standing between a wounded patient and death. Here in Kyoto, at Daktari Animal Hospital, that fragility is measured in three dogs on a list. Researchers at Osaka Metropolitan University are now reaching toward a different kind of answer, coaxing red blood cells from stem cells so that future animals might no longer depend on the willingness of other animals to give. The path is still lo
Japan Vets Turn to Stem Cells as Canine Blood Shortage Strains Emergency Care
Dogs suffering severe blood loss face death during surgery or emergencies when transfusions are unavailable, and some owners are told their pets' survival will be difficult.
Only about 3% of the original iPS cells became red blood cell-like cells.
Mark
Why is dog blood so hard to come by in Japan? People assume it's like human blood.
Mimi
It isn't. Humans have a nationwide supply system. Dogs don't, so each hospital has to build its own stock. Daktari in Kyoto has only three registered donor dogs.
Mark
And the old solution, keeping donor dogs on site?
Mimi
Mori says that was once common, but welfare concerns have made it harder. Owners are also reluctant to let their dogs be sedated for a blood draw.
Luke
Worth noting that the account of owner reluctance comes from Mori's experience at one hospital. We don't have survey figures on how widespread it is.
Mark
What about the regulations? Could sharing between hospitals fix it?
Mimi
Canine blood is classed as a veterinary drug, so transfer and sale are restricted. But Mori doesn't think relaxing the rules alone would solve it, because the donors simply aren't there.
Mark
The surgery detail is striking, returning blood from a ruptured tumour.
Mimi
Yes. It risks spreading cancer cells if the tumour is malignant, but he says it beats a dog dying for lack of blood.
Luke
We should be careful there. That's one vet's judgement of a tradeoff. The report gives no data on how often it's done or how often it goes wrong.
Mark
And the stem cell research?
Mimi
Hatoya's team got cells resembling red blood cells with hemoglobin after nearly a month of culture, but only about 3% of the iPS cells made the change.
Luke
And the report gives no timeline. Hatoya states a hope, not a date. Whether this ever becomes a real transfusion product is unknown.
El Pulso
- A Kyoto animal hospital runs its emergency blood bank on just three donor dogs, and its director admits plainly that it is not enough.
- Japan has no nationwide canine blood supply, so every clinic must scramble to keep its own donors and stocks alive.
- Surgeons face agonizing choices, such as returning blood from ruptured tumours even though it may spread cancer cells.
- Osaka researchers have grown red blood cell-like cells from dog iPS cells, but only about 3% converted, so donor-free transfusions remain years away.
In a country where human blood is pooled through a national network but no equivalent exists for dogs, veterinary clinics in Japan are left to fend for themselves, sometimes with only a handful of donor animals standing between a wounded patient and death. Here in Kyoto, at Daktari Animal Hospital, that fragility is measured in three dogs on a list. Researchers at Osaka Metropolitan University are now reaching toward a different kind of answer, coaxing red blood cells from stem cells so that future animals might no longer depend on the willingness of other animals to give. The path is still long, and the laboratory's modest yield reminds us that between an idea and a remedy lies a great deal of patient work.
At Daktari Animal Hospital in Kyoto, the blood bank rests on a registry of just three donor dogs. When a dog arrives bleeding heavily from an accident, or when surgery turns dangerous, those three are all the hospital can call on. The director, Takashi Mori, says it without ornament: "We just don't have enough blood."
The problem is built into the system. Japan has a nationwide network for human blood, but nothing comparable exists for dogs, so each veterinary hospital must gather and store its own supply. Once, vets kept dogs on site as donors. Welfare concerns have made that increasingly difficult, and strict limits on how much blood can be drawn, and how often, mean that staff sometimes bring in their own pets when stocks run low.
The shortage reaches into the operating room. When a tumour ruptures, the spilled blood can be suctioned and returned to the patient, though if the tumour is malignant this risks spreading cancer cells. Mori judges that the lesser evil: a dog dying on the table for lack of blood is worse. For animals needing regular transfusions, some owners are told that keeping their pets alive will be hard.
A team at Osaka Metropolitan University, led by Shingo Hatoya, is working toward a different future. In research announced in July, they produced cells resembling red blood cells from canine iPS cells, containing hemoglobin. Yet only about 3% of the starting cells made the change, so the technology is not ready for transfusions. Hatoya hopes that one day dogs can receive blood "without relying on donors, improving the lives of both dogs and their owners."
For now, hospitals like Daktari will keep managing with small registries and borrowed pets. The question to watch is whether that conversion rate can climb well beyond 3%.
At Daktari Animal Hospital in Kyoto, the blood bank runs on a registry of just three donor dogs. That is the full roster the hospital can call on when a dog arrives with severe blood loss from an accident, or when surgery goes badly. It is not enough, and the hospital's director, Takashi Mori, says so plainly: "We just don't have enough blood."
The problem is structural. Japan has a nationwide supply system for human blood, but nothing comparable exists for dogs. Each veterinary hospital has to secure its own stocks. Daktari does this by regularly collecting and storing blood, and by keeping the registry of dogs that can be brought in for emergency donations.
There was a time when vets commonly kept dogs on site as blood donors, Mori said. Animal welfare concerns have made that increasingly difficult. The limits on the dogs that do donate are tight: the amount of blood that can be taken from each one depends on its weight, and enough time has to pass between donations to protect the animal's health. When supplies run especially low, hospital staff sometimes bring in their own dogs to give blood.
The shortage reaches into the operating room. When a tumour ruptures during surgery, the blood it releases can be suctioned out and returned to the dog's body. If the tumour is malignant, that carries a risk of spreading cancer cells. Mori said the alternative may be worse. "It's better than having a dog die during surgery because it didn't receive enough blood," he said. For dogs with conditions that call for regular transfusions, vets sometimes have to tell owners that keeping their pets alive will be difficult.
Building a wider network is not simple. Under Japan's pharmaceutical regulations, canine blood is classified as a veterinary drug, and restrictions on its transfer and sale make it hard for neighbouring hospitals to share what they have. Yet Mori does not believe loosening those rules would fix the underlying shortage. When hospitals appeal for donations, few owners are willing to let their dogs be sedated and have blood drawn. Keeping dogs solely as donors is impractical on welfare grounds, and the limited supply leaves little prospect of a commercially viable large-scale blood bank.
That is the gap a team at Osaka Metropolitan University, led by professor Shingo Hatoya, is trying to address. The researchers are working to produce canine red blood cells from induced pluripotent stem cells, known as iPS cells, which can develop into various types of cells in the body. In research announced in July, the team added several proteins to canine iPS cells and cultured them for nearly a month. The result was cells resembling red blood cells that contained hemoglobin, an essential component of blood.
The yield, however, is small. Only about 3% of the original iPS cells became red blood cell-like cells, which means the technology is not yet ready for use in transfusions. Hatoya nonetheless hopes the work will eventually let dogs receive transfusions without depending on donors. "I want to create a system in which dogs can receive blood transfusions without relying on donors, improving the lives of both dogs and their owners," he said.
For now, hospitals like Daktari will keep managing with small registries and borrowed pets. The thing to watch is whether the conversion rate from iPS cells can rise well beyond 3%.
Citas Notables
We just don't have enough blood.— Takashi Mori, director, Daktari Animal Hospital
I want to create a system in which dogs can receive blood transfusions without relying on donors, improving the lives of both dogs and their owners.— Shingo Hatoya, Osaka Metropolitan University professor
Quieres la nota completa?
Lee el original en The Straits Times ↗
Health & Medicine